Guardant Health Inc (NAS:GH)
$ 29.54 0 (0%) Market Cap: 3.61 Bil Enterprise Value: 3.83 Bil PE Ratio: 0 PB Ratio: 52.66 GF Score: 70/100

Guardant Health Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 15, 2020 / 03:45PM GMT
Release Date Price: $103.1 (-0.05%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Hello, everyone. Thanks for joining us today on day 2 of our Healthcare conference. I am Tejas Savant, and I cover the Life Science Tools and Diagnostics Sector here at Morgan Stanley. Delighted to have Guardant Health join us today and representing the company are Helmy Eltoukhy, CEO; and Derek Bertocci, CFO. So welcome to you both, guys.

Helmy Eltoukhy
Guardant Health, Inc. - Co-Founder, CEO & Director

Thanks for having us.

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Before we kick it off, I just have a quick disclaimer to read. Please note that the webcast is for Morgan Stanley's clients and appropriate employees only. The webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please go to organstanley.com/researchdisclosures. And if you have any questions, please reach out to your sales rep.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot